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The major component of the epidermis, keratinocytes, must continuously proliferate and differentiate to form the mechanical and water
permeability barrier of the skin. Our previous data have suggested a potential role in these processes for phospholipase D (PLD), an enzyme
that hydrolyzes phospholipids to generate phosphatidic acid. In the presence of primary alcohols, PLD also catalyzes a transphosphatidylation
reaction to produce phosphatidylalcohols, and this characteristic has been exploited to monitor the activity of PLD in intact cells. In this
report, PLD was demonstrated to utilize the physiological alcohol glycerol to form phosphatidylglycerol (PG) in vitro. In intact primary
murine epidermal keratinocytes treated for 24 h with elevated extracellular Ca2 + levels, but not 1,25-dihydroxyvitamin D3, incubation with
radioactive glycerol resulted in an increase in PLD-mediated radiolabeled PG production. This effect was dose-dependent and biphasic, with
maximal PG formation detected after exposure to an intermediate (125 AM) Ca2 + concentration. Furthermore, the biphasic nature of the
response was due, in part, to a corresponding biphasic change in glycerol uptake. Finally, short-term treatment of keratinocytes with phorbol
12-myristate 13-acetate (PMA) failed to increase PG synthesis and inhibited glycerol uptake. Since (1) PMA is reported to activate PLD-1 to
a greater extent than PLD-2, (2) 1,25-dihydroxyvitamin D3 increases the expression/activity of PLD-1 in keratinocytes, and (3) PLD-2 is co-
localized with a glycerol channel in keratinocyte membrane microdomains, we speculate that radiolabeled PG production from radioactive
glycerol is a measure of PLD-2 activation in these cells. Our results also suggest that PLD-mediated PG synthesis may be regulated at the
level of both PLD activity and alcohol substrate availability via changes in glycerol uptake.
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1. Introduction phospholipase D (PLD) in this process. Indeed, there areThe epidermis is a continuously regenerating tissue,
which differentiates to produce a mechanical and water
permeability barrier, thus protecting the organism from
infection and making possible a terrestrial existence. The
physiological signaling pathways controlling formation of
this barrier are not completely understood; however, data
from our and other laboratories suggest a possible role for0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamer.2003.08.006
Abbreviations: PG, phosphatidylglycerol; PKC, protein kinase C; PLD,
phospholipase D; PMA, phorbol 12-myristate 13-acetate; SFKM, serum-
free keratinocyte medium
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E-mail address: wbollag@mail.mcg.edu (W.B. Bollag).numerous data supporting a role for PLD in the differenti-
ation of keratinocytes (reviewed in Ref. [1]), the primary
cell components of the epidermis. For example, ganglioside
GQ1b induces PLD activation, a sustained elevation in DAG
content and induction of keratinocyte differentiation [2,3].
Studies in our laboratory also provide evidence for an
involvement of sustained PLD activation in keratinocyte
differentiation. Specifically, incubation of epidermal kerati-
nocytes with bacterial PLD results in inhibition of prolifer-
ation and an increase in the activity of a marker of
differentiation, transglutaminase [4]. In addition, agents that
elicit sustained PLD activation, such as staurosporine and
phorbol 12-myristate 13-acetate (PMA), also induce trans-
glutaminase activity in primary mouse keratinocytes [5].
Finally, we have shown that the differentiating agent, 1,25-
dihydroxyvitamin D3 stimulates PLD activity over time by
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1), and that this expression correlates with late (granular)
differentiation [6]. Thus, we have proposed that PLD
activity may mediate keratinocyte differentiation, presum-
ably be increasing DAG and activating one or more protein
kinase C (PKC) isoenzymes (reviewed in Ref. [1]).
Two isoforms of PLD, PLD-1 and PLD-2, have been
cloned, sequenced, and characterized (reviewed in Refs. [7–
9]). Both isoenzymes utilize phosphatidylcholine as a sub-
strate and require phosphatidylinositol 4,5-bisphosphate as a
cofactor. PLD-1 is regulated by a variety of factors includ-
ing ADP ribosylation factor, the small GTP-binding protein,
RhoA, and PKC-a (reviewed in Refs. [7–9]). PLD-2, on the
other hand, exhibits constitutive activity when transfected
into insect cells [10], leading to the speculation that under
basal conditions, this isoenzyme is negatively regulated in
mammalian cells. However, this idea has recently been
questioned and the suggestion made that PLD-2 activity is
regulated by phosphatidylinositol 4,5-bisphosphate levels
[11]. Other studies in intact cells suggest a role for ADP
ribosylation factor and/or PKC in the regulation of PLD-2
activity as well [12–17]. In addition to distinct mechanisms
of regulation, functional disparities of the two PLD iso-
enzymes have been indicated, with PLD-1 thought to play a
role in secretory pathways and PLD-2 involved in cytoskel-
etal rearrangements and membrane ruffling ([10,18] and
reviewed in Ref. [8]). Finally, there also appear to be
differences in cellular distribution patterns of these two
isoforms. Thus, PLD-1 localizes predominantly to intracel-
lular membranes, whereas PLD-2 associates with the plasma
membrane ([10,19] and reviewed in Ref. [8]). Indeed, PLD-
2 has been shown to localize to caveolin-rich membrane
microdomains within the plasma membrane in primary
mouse keratinocytes and a human keratinocyte cell line
[20,21]. Our data also indicate a co-localization of PLD-2
with a glycerol channel, aquaporin-3, in these microdo-
mains, as demonstrated by their similar distributions in
fractionated cells and upon microdomain disruption by the
cholesterol depleting reagent, h-cyclodextrin, by co-immu-
noprecipitation of vesicle populations and by confocal
microscopy [21]. In addition, the interaction between
PLD-2 and aquaporin-3 appears to be protein-mediated,
since these proteins, but not caveolin-1, co-immunoprecip-
itate in the presence of non-ionic detergent [21].
In this report, we provide evidence that a long-term
exposure of keratinocytes to elevated extracellular calcium
concentrations, but not 1,25-dihydroxyvitamin D3, increases
PLD-mediated [3H] or [14C] phosphatidylglycerol (PG)
synthesis in cells labeled with [3H] or [14C]glycerol. This
increase in radiolabeled PG production upon chronic ele-
vated extracellular calcium exposure may be, in part, the
result of an increase in glycerol uptake, which is increased
in a biphasic manner, with maximal radiolabeled glycerol
uptake observed after treatment with 125 AM calcium-
containing medium and a decrease elicited by both high
(1 mM) calcium and 1,25-dihydroxyvitamin D3. In addition,PMA increases PLD activity but does not enhance PG
formation and inhibits glycerol uptake. Since (1) PMA is
reported to activate PLD-1 to a greater extent than PLD-2
[8], (2) in keratinocytes PLD-1, but not PLD-2, expression
and activity is increased by 1,25-dihydroxyvitamin D3 [6]
and (3) PLD-2 is co-localized with a glycerol channel in
keratinocyte membrane microdomains [21], we hypothesize
that radiolabeled PG production upon exposure to glycerol
is a measure of PLD-2 activity in keratinocytes. Finally, we
propose that in keratinocytes, the functional interaction
between PLD-2 and a glycerol channel (presumably aqua-
porin-3 [21]) regulates the synthesis of PG, which may
therefore serve as a novel signaling lipid important in
mediating keratinocyte differentiation in response to elevat-
ed extracellular calcium levels.2. Experimental
2.1. Materials
Membranes obtained from Sf9 insect cells overexpress-
ing PLD-2 were a generous gift from Dr. Nancy Pryer
(Onyx Pharmaceuticals, Richmond, CA). [3H]Oleic acid,
[3H-palmitoyl]phosphatidylcholine, [3H]glycerol (three dif-
ferent forms were used as products were discontinued:
[1,2,3-3H]glycerol (specific activity of 200 mCi/mmol),
[1,2,3-3H]glycerol (specific activity of 40–80 mCi/mmol)
and [2-3H]glycerol (specific activity of 200 mCi/mmol)) and
[1,3-14C]glycerol were obtained from NEN/DuPont (Boston,
MA). In some experiments, [3H-(1,2,3)]glycerol and [14C-
(U)]glycerol were obtained from American Radiolabeled
Chemicals (St. Louis, MO). Phosphatidylethanolamine,
phosphatidylcholine and standards of phosphatidylethanol,
phosphatidic acid and phosphatidylglycerol were purchased
from Avanti Polar Lipids (Alabaster, AL). Phosphatidylino-
sitol 4,5-bisphosphate was obtained from Calbiochem (San
Diego, CA) or Sigma (St. Louis, MO). Calcium-free MEM
and antibiotics were purchased from Biologos, Inc. (Maper-
ville, IL). Bovine pituitary extract, epidermal growth factor
and HEPES solution (1M, pH 7.4) were obtained fromGibco
BRL (Grand Island, NY). ITS+ was supplied by Collabora-
tive Biomedical Products (Bedford, MA) and dialyzed fetal
bovine serum byAtlanta Biologicals (Atlanta, GA). Silica gel
60 TLC plates with concentrating zone were obtained from
EM Science (Gibbstown, NJ). All other reagents were
obtained from standard suppliers and were of the highest
grade available.
2.2. In vitro assay of PG formation
PLD-2 activity was measured in vitro with [3H-palmi-
toyl]phosphatidylcholine as substrate. Radiolabeled phos-
phatidylcholine was incorporated into lipid vesicles
prepared from phosphatidylethanolamine, phosphatidylcho-
line and phosphatidylinositol 4,5-bisphosphate as described
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the liposomes and the reaction initiated by the addition of
PLD-2-overexpressing Sf9 cell membranes, which were
generously provided by Dr. Nancy Pryer (Onyx Pharma-
ceuticals). The reaction was then allowed to proceed at 37
jC for 30 min prior to termination by the addition of 0.2%
SDS containing 5 mM EDTA. Lipids were extracted accord-
ing to the method of Bligh and Dyer and radiolabeled
phospholipids separated and quantified, as described in
Ref. [22].
2.3. Cell culture
Primary epidermal keratinocytes were prepared from 1-
to 3-day-old neonatal ICR mice after trypsin flotation of
the skin and mechanical separation of the epidermis from
the dermis. The epidermal cells were released by scrap-
ing, collected by centrifugation and plated in six-well
dishes in a medium consisting of MEM containing 25 AM
calcium, 2% dialyzed fetal bovine serum, 2 mM gluta-
mine, 5 ng/ml EGF, ITS+ (6.25 Ag/ml insulin + 6.25 Ag/ml
transferrin + 6.25 ng/ml selenious acid + 5.35 Ag/ml lino-
leic acid + 1.25% bovine serum albumin), 100 U/ml
penicillin, 100 Ag/ml streptomycin and 0.25 Ag/ml fungi-
zone. After an overnight incubation, the cells were re-fed
with serum-free keratinocyte medium (SFKM), in which
2% dialyzed fetal bovine serum was replaced with 90 Ag/
ml bovine pituitary extract. Cells were re-fed with fresh
medium every 1–3 days.
2.4. PLD activity and [3H] or [14C]PG formation
For the PLD assay, cultured primary keratinocytes
were labeled for 20–24 h with 2.5 ACi/ml [3H]oleic acid.
The cells were then exposed to vehicle or 100 nM PMA
in the presence of 0.5% ethanol for 30 min. For experi-
ments with 125 AM calcium concentrations, keratinocytes
were exposed for 24 h to 25 AM (control) or 125 AM
calcium-containing medium in the presence of 2.5 ACi/ml
[3H]oleic acid followed by the addition of 0.5% ethanol
for 30 min and extraction of phospholipids. To measure
the formation of radiolabeled PG, cells were treated for
24 h with SFKM containing vehicle, 250 nM 1,25-
dihydroxyvitamin D3 or 125 AM calcium and then labeled
for an additional 30 min with 2.5–5 ACi/ml [3H]glycerol.
For experiments investigating the extracellular calcium
dependence of PG formation, cells were incubated for
24 h in SFKM containing various calcium concentrations
prior to the addition of 5 ACi/ml [3H]glycerol for 30 min.
In some cases, cells were stimulated with 25 AM calcium
(control)- or 125 AM calcium-containing SFKM for 24
h prior to the addition of 0.5–1 ACi/ml [14C]glycerol in
the presence and absence of 1% ethanol. To measure PG
formation in response to PMA, unlabeled cells were
stimulated with 100 nM PMA in the presence of radio-
labeled [3H]glycerol, as above. Reactions were terminatedand the radiolabeled phosphatidylalcohol extracted, sepa-
rated by thin-layer chromatography and quantified as
described in Ref. [22].
2.5. Demonstration of radiolabel in the headgroup position
of [14C]PG
Keratinocytes pretreated for 24 h with control (25 AM
calcium) or 125 AM calcium-containing medium were
exposed to 0.4–0.5 ACi/ml [14C]glycerol for an additional
30 min. Lipids were extracted into chloroform/methanol
as described above. Dried lipid extracts were then solu-
bilized in phospholipase buffer (100 mM Tris, pH 7.4, 6
mM MgCl2 + 0.1% Triton X-100) by extensive vortexing
and a short incubation at 37 jC, and approximately half
of each extract was transferred into each of two clean
tubes. Distilled water (untreated) or 1 IU/ml (final con-
centration) of Streptomyces chromofuscus PLD (Sigma)
diluted in distilled water (PLD-treated) was then added to
each of the lipid extract samples, which were incubated at
37 jC for 60 min. Released headgroups were then
separated from phospholipids by extraction into the aque-
ous layer, essentially according to the method of Folch et
al. [23]. Briefly, 75-Al reaction mixtures were diluted with
1.5 ml of chloroform/methanol (2:1 volume/volume) fol-
lowed by the addition of 300 Al of 0.05 M NaCl. A
portion of the upper aqueous layer was then collected and
quantified by liquid scintillation spectrometry. PLD-re-
leased radioactivity in the aqueous phase was calculated
as the amount released in the PLD-treated sample minus
the amount detected in the corresponding untreated sam-
ple. In other experiments, PG was first isolated from lipid
extracts by thin-layer chromatography as described above
and visualized with iodine vapor. PG was extracted from
the thin-layer plate using chloroform/methanol (2:1 vol-
ume/volume) and dried under nitrogen. The isolated PG
was then solubilized, incubated with and without bacterial
PLD and extracted as above. Following removal of the
aqueous aliquot for counting, the remaining aqueous
phase was aspirated, and the organic phase dried under
nitrogen. This lipid extract was then separated by thin-
layer chromatography and PG and phosphatidic acid in
the samples quantified as above.
2.6. [3H]Glycerol uptake
Confluent primary keratinocytes were incubated for 30,
60, 90, 120, 300 or 600 s with SFKM containing 20 mM
HEPES (for additional pH buffering), 1 ACi/ml [3H]glyc-
erol and 0.1% DMSO (control) or 100 nM PMA. Reac-
tions were terminated by washing three times with ice-cold
phosphate-buffered saline lacking divalent cations. The
cells were subsequently solubilized in 0.3 M NaOH and
aliquots of this extract subjected to liquid scintillation
counting. Counts obtained from duplicate samples at each
time point were averaged and graphed, and a linear
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coefficients obtained were typically 0.99 or greater (mean
correlation coefficient for control was 0.992F 0.002 and
for PMA, 0.994F 0.001). Slopes obtained from multiple
experiments were averaged and analyzed statistically for
significant differences between conditions.
The linearity of glycerol uptake determined above
allowed measurement of uptake at a single time point
to determine the effects of other treatments on this
process. Thus, confluent keratinocytes were preincubated
for 30 min with 0.1% DMSO (control) or 100 nM PMA
prior to measuring [3H]glycerol uptake as above but at 5
min only. Similarly, near-confluent primary keratinocytes
were incubated for 24 h with SFKM containing various
calcium concentrations prior to measurement of radio-
labeled glycerol uptake for 5 min.
2.7. Statistical analysis
The significance of differences between mean values was
determined using analysis of variance (ANOVA), as per-
formed by the program Instat (GraphPad Software, San
Diego, CA).Fig. 1. Glycerol serves as a substrate for PLD in the transphosphatidylation
reaction in vitro. Liposomes were prepared from [3H-dipalmitoyl]phospha-
tidylcholine, phosphatidylethanolamine, phosphatidylcholine and phospha-
tidylinositol 4,5-bisphosphate by sonication, as described in Ref. [6].
Glycerol at the indicated concentrations in the absence (A) or presence of
1% ethanol (B) was added to the reaction mix. Reactions were initiated by
the addition of Sf9 PLD2-overexpressing membranes (1 Ag protein),
incubated for 30 min at 37 jC and terminated by the addition of 0.2% SDS
(F 5 mM EDTA). Lipids were extracted, separated and quantified as
described in Ref. [22]. The figure is representative of at least two additional
experiments. There was some variability in the absolute levels of PA, PG
and phosphatidylethanol (PEt) formed, likely due to variations in the extent
of formation of multilamellar vesicles during sonication.3. Results
3.1. PLD-2 utilizes glycerol as a primary alcohol for the
transphosphatidylation reaction in vitro (characterization of
the response)
In intact cells, PLD has the unique property of
catalyzing not only the hydrolysis of phospholipids to
form phosphatidic acid but also, in the presence of
primary alcohols, a transphosphatidylation reaction that
results in the production of phosphatidylalcohols. Thus,
the generation of phosphatidylalcohols has been used as a
measure of PLD activity. Typically, primary alcohols such
as ethanol or 1-butanol are used since this results in the
production of novel phosphatidylalcohols that are not
readily metabolized by the cell. Previous studies in intact
cells have suggested that the physiological primary alco-
hol, glycerol, can also serve as a substrate for the trans-
phosphatidylation reaction [24– 26]. Using PLD-2-
overexpressing Sf9 membranes, we investigated whether
glycerol is a substrate for PLD-2 in vitro. As shown in
Fig. 1A, PLD-2 catalyzed the formation of PG from
phosphatidylcholine in the presence of glycerol. This
formation was dependent on the concentration of glycerol
in the reaction mix (Fig. 1A), as well as the amount of
PLD-2 added and the time of incubation (data not
shown). Furthermore, glycerol could compete with the
primary alcohol ethanol to generate PG in place of
phosphatidylethanol (Fig. 1B). PLD-1 was also observed
to generate PG in vitro in the presence of glycerol (data
not shown).3.2. The production of radiolabeled PG, formed upon
addition of [3H] or [14C]glycerol to intact cells, is increased
upon exposure of keratinocytes to an elevated calcium
concentration and decreased with 1,25-dihydroxyvitamin D3
treatment
We have shown previously that the keratinocyte-differ-
entiating agent, 1,25-dihydroxyvitamin D3 increases PLD-1
expression and activity after a 24-h exposure [6]. We next
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another agent that triggers keratinocyte differentiation,
elevated extracellular calcium levels, on PG formation in
cells pretreated for 24 h prior to addition of [3H]glycerol.
Based on our previous results [6], we anticipated that 1,25-
dihydroxyvitamin D3 would increase the generation of PG,
since this agent stimulated PLD-1 activity and expression.
Unexpectedly, exposure to 1,25-dihydroxyvitamin D3 did
not increase radiolabeled PG formation relative to control
cells, and in fact, there was instead an apparent decrease
observed (Fig. 2), presumably because of the ability of
1,25-dihydroxyvitamin D3 to inhibit glycerol uptake into
the cells [21]. On the other hand, pretreatment with 125Fig. 2. PG formation is increased in differentiating cells exposed to
elevated extracellular calcium concentrations but not 1,25-dihydroxyvita-
min D3. Near-confluent keratinocytes were incubated with 25 AM-calcium-
SFKM containing vehicle (Con; 0.05% ethanol), 250 nM 1,25-dihydrox-
yvitamin D3 (D3) or 125 AM calcium ( + 0.05% ethanol; Ca2 +) for 24 h.
2.5–5 ACi/well [3H]glycerol were then added for an additional 30 min at
37 jC. Reactions were terminated by the addition of 0.2% SDS ( + 5 mM
EDTA) and phospholipids extracted, separated and quantified as described
in Section 2. Results are expressed as -fold over the control value and
represent the meansF S.E. of three separate experiments; *P< 0.001
versus the control. The thin-layer chromatogram shown in Panel B is
representative of the three experiments quantified in Panel A.AM calcium-containing medium induced an increase in the
subsequent production of PG (Fig. 2). This result sug-
gested a possible elevated calcium-induced activation of
PLD, although at this point there existed the possibility
that other pathways, such as the more traditional mecha-
nism in which glycerol-3-phosphate is added to CDP-
diacylglycerol [discussed on the web site of the Lipid
Analysis Group of the Scottish Crop Research Unit (URL
address: www.lipid.co.uk/infores/Lipids/pg)], might be in-
volved in PG synthesis.
3.3. The effect of elevated calcium concentrations on PG
production, and glycerol uptake, is dose-dependent
Elevated extracellular calcium levels induce various
stages of keratinocyte differentiation in a concentration-
dependent manner. Thus, calcium concentrations in the
range of 100–125 AM stimulate the expression of keratin-
1, a marker of early (spinous) differentiation, whereas
higher concentrations induce markers of later differentia-
tion [27], e.g., transglutaminase activity. We investigated
the dose-dependence of the effect of elevated extracellular
calcium levels on PG production. PG formation in re-
sponse to elevated extracellular calcium concentrations
[over the range 25 AM (control) to 1 mM] exhibited a
biphasic dose dependence (Fig. 3A). Thus, maximal stim-
ulation of radiolabeled PG formation was observed at 125
AM calcium, with a gradually declining effect at higher
calcium concentrations.
The ability of intermediate calcium concentrations to
stimulate PG formation maximally could be the result of
an increase in glycerol uptake, an enhancement of PLD
activity or both. The effect of pretreatment of keratino-
cytes with various calcium concentrations on subsequent
radiolabeled glycerol uptake was determined as described
in Section 2. Preexposure to 125 and 250 AM calcium-
containing medium induced an increase (of 56% and
41%, respectively) in glycerol uptake relative to the 25
AM calcium control, whereas glycerol uptake in 500 AM-
calcium-pretreated keratinocytes was approximately
equivalent to the control value (Fig. 3B). On the other
hand, a concentration of 1 mM induced a slight but not
significant inhibition (in these experiments) of glycerol
uptake. Although the small increase in glycerol uptake
observed with 125 AM calcium pretreatment could con-
tribute to enhanced PG synthesis, the effect on glycerol
uptake by itself is unlikely to account for the large
increase in radiolabeled PG production, suggesting that
PLD might also be activated by the intermediate calcium
concentration.
The ability of intermediate calcium concentrations to
stimulate PG synthesis suggested that this process was
associated with early differentiation events. Therefore, we
examined the effect of an intermediate 1,25-dihydroxyvi-
tamin D3 concentration, known to stimulate expression of
the early differentiation marker keratin-1 (10 nM; [28]), on
Fig. 4. PG formation is inhibited in differentiating cells exposed to
intermediate and high concentrations of 1,25-dihydroxyvitamin D3. Near-
confluent keratinocytes were incubated with SFKM containing 0.05%
ethanol (Con), 10 nM 1,25-dihydroxyvitamin D3 or 250 nM 1,25-
dihydroxyvitamin D3 (D3) for 24 h. 2.5-5 ACi/well [3H]glycerol were then
added for an additional 30 min at 37 jC. Reactions were terminated by the
addition of 0.2% SDS ( + 5 mM EDTA) and phospholipids extracted,
separated, quantified as described in Section 2 and expressed as -fold over
the control value. Results represent the meansF S.E. of three separate
experiments; *P < 0.01, **P< 0.001 versus the control.
Fig. 3. Elevated extracellular calcium concentration increases PG
production, and to a lesser extent glycerol uptake, in a dose-dependent
manner. Near-confluent keratinocytes were incubated with SFKM
containing various concentrations of calcium for 24 h. (A) The cells
were then incubated for an additional 30 min with 5 ACi/well [3H]glycerol
prior to termination of reactions with 0.2% SDS (F 5 mM EDTA) and
extraction, separation and quantification of radiolabeled PG. Values are
expressed as -fold over the control (25 AM-calcium-SFKM) and represent
the meansF S.E. of five separate experiments; *P< 0.05 versus the control
value. (B) After a 24-h pretreatment with various calcium concentrations,
the cells were incubated for 5 min with 1 ACi/well [3H]glycerol in SFKM
containing 20 mM HEPES, prior to termination of reactions by extensive
washing with ice-cold phosphate-buffered saline lacking divalent cations,
as described in Section 2. Values are expressed as -fold over the control
(25 AM-calcium-SFKM) and represent the meansF S.E. of five separate
experiments; **P < 0.01, *P< 0.05 versus the control value.
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intermediate calcium concentrations, 1,25-dihydroxyvita-
min D3 did not increase PG synthesis, and in fact, both
the intermediate (10 nM) and high (250 nM) concentra-
tions of 1,25-dihydroxyvitamin D3 significantly inhibited
PG production (Fig. 4).3.4. Increased radiolabeled PG formation upon treatment
with an elevated calcium concentration in intact cells is
mediated, at least in part, by PLD
As observed in Fig. 2B, elevated extracellular calcium
concentration appeared to induce an increase not only in
the synthesis of PG but also of phosphatidic acid. There-
fore, it was possible that elevated calcium levels enhanced
general phospholipid synthesis, stimulating glycerol incor-
poration into the phospholipid backbone rather than the
headgroup, and that therefore increased PG synthesis
occurred independently of PLD activity. Since ethanol
and glycerol both act as a substrate for the transphospha-
tidylation reaction (Fig. 1B), we used ethanol to determine
whether elevated extracellular calcium concentration-eli-
cited stimulation of PG formation occurred through the
activation of PLD. Ethanol (1%) was added to keratino-
cytes pretreated with 125 AM calcium minutes before
initiation of PG production with [14C]glycerol. As shown
in Fig. 5, ethanol significantly inhibited PG formation
stimulated by preexposure to elevated extracellular calcium
levels, without affecting basal (control) PG production.
The ability of ethanol to compete with glycerol suggests
that at least some of the elevated calcium-stimulated PG
formation is the result of an enhancement of PLD activity.
This idea is also supported by our finding that in [3H]ole-
ate-labeled cells treated for 24 h with 25 AM (control) or
125 AM calcium-containing medium and exposed to 0.5%
Fig. 6. Increased radiolabel was released by bacterial PLD from PG isolated
from elevated extracellular calcium-pretreated versus control cells. Near-
confluent keratinocytes were incubated with 25 AM-calcium SFKM
(control) or 125 AM-calcium SFKM for 24 h. The cells were then
incubated for an additional 30 min with 1 ACi/well [14C]glycerol, followed
by extraction of the lipids into chloroform/methanol and separation of PG
by thin-layer chromatography as described in Section 2. After solubiliza-
tion, PG isolated from control (Con) or 125 AM calcium-treated (Ca2 +)
cells was incubated with (PLD) or without (H2O) bacterial PLD, and the
radioactivity remaining in PG (light striped bars) and PA (dark striped bars)
was quantified after thin-layer chromatographic separation as described in
Section 2. Values represent the meansF S.E. from three experiments;
*P < 0.001 versus the corresponding untreated control value, jP < 0.001
versus the corresponding untreated calcium-treated value.
Fig. 5. The extracellular calcium concentration-stimulated PG formation is
inhibited by ethanol. Near-confluent keratinocytes were incubated with 25
AM-calcium SFKM (control) or 125 AM-calcium SFKM for 24 h. The cells
were then incubated for an additional 30 min with 0.5–1 ACi/well
[14C]glycerol in the presence and absence of 1% ethanol. Reactions were
terminated by the addition of 0.2% SDS (F 5 mM EDTA) and radiolabeled
PG was extracted, separated by thin-layer chromatography and quantified.
Values are expressed as -fold over the control (without ethanol) and
represent the meansF S.E. of four separate experiments; *P < 0.01,
**P < 0.001 versus the control value, jP < 0.01 versus 125 AM calcium-
SFKM alone.
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creased by the elevated calcium concentration (1.9F 0.2-
fold over the control value of 1.0; P < 0.05, n = 4), indi-
cating a stimulation of PLD activity.
The involvement of PLD in elevated extracellular
calcium-induced PG synthesis was further demonstrated
by the ability of bacterial PLD to release radiolabel from
lipid extracts and isolated PG. In these experiments, cells
were pretreated with or without 125 AM calcium-contain-
ing medium for 24 h prior to addition of [14C]glycerol for
30 min. Lipid extracts were then prepared, solubilized in a
Triton-X-100-containing buffer and incubated with or
without bacterial PLD for 1 h. This bacterial PLD has
been used previously to quantify PG in amniotic fluid,
through its ability to release the glycerol headgroup [29].
Released headgroups were then partitioned into the aque-
ous phase using the Folch et al. method [23], as described
in Section 2. Upon incubation with bacterial PLD,
[14C]glycerol-labeled lipid extracts from 125 AM calci-
um-pretreated cells released approximately four times the
amount of radiolabel into the aqueous fraction as those
from control-pretreated cells (control, 1.00F 0.09; calci-
um, 4.2F 0.4-fold over the control level; P < 0.001 with
values representing the meansF S.E. of six samples from
three separate experiments). This result suggests that more
glycerol was being incorporated into the headgroup posi-tion with calcium exposure, consistent with enhancement
of a PLD-mediated transphosphatidylation reaction.
Similar experiments using PG isolated from control or
elevated extracellular calcium-pretreated cells are shown in
Fig. 6. Again, bacterial PLD released greater than 3-fold
more radioactivity from PG isolated from 125 AM calcium-
pretreated cells than from control cells (control, 1.00F 0.04;
calcium, 3.3F 0.5-fold over the control level; P < 0.01 with
values representing the meansF S.E. of six samples from
three separate experiments). Thin-layer chromatographic
analysis of the bacterial PLD-treated and -untreated PG
samples demonstrated that a portion of the radiolabeled
PG was converted to radiolabeled PA, indicating that some
of the glycerol was present in the phospholipid backbone as
well (Fig. 6). However, only approximately 40% of the
original radiolabel found in PG was recovered in PA,
indicating that approximately 60% of the radiolabel in PG
was present in the headgroup position.
3.5. Phorbol ester increases PLD activity but does not
increase radiolabeled PG formation
Another agent known to induce both sustained PLD
activity in intact cells and keratinocyte differentiation [5]
Fig. 8. Pretreatment, but not simultaneous incubation, with PMA inhibits
[3H]glycerol uptake. Glycerol uptake was measured in cells pretreated or
treated simultaneously with and without PMA. For the ‘‘no pretreatment’’
samples, cells were incubated for 5 min in SFKM containing 20 mM
HEPES, 1 ACi/ml [3H]glycerol and 0.1% DMSO (control) or 100 nM PMA.
For the ‘‘30-min pretreatment with PMA’’ samples, confluent keratinocytes
were preincubated for 30 min in SFKM containing 0.1% DMSO (control)
or 100 nM PMA. Cells were then incubated for 5 min in SFKM containing
X. Zheng et al. / Biochimica et Biophysica Acta 1643 (2003) 25–3632is the phorbol ester, PMA. We therefore determined the
effect of PMA on PG formation. PMA actually elicited a
significant (P < 0.01 by unpaired Student’s t-test) decrease
in PG production (Fig. 7, right), despite the fact that it
simulated a large increase in PLD activity, monitored using
the formation of radiolabeled phosphatidylethanol in
[3H]oleate-prelabeled as a measure (Fig. 7, left). The ability
of PMA to inhibit radiolabeled PG production could be the
result of a PMA-mediated decrease in glycerol uptake.
Simultaneous incubation of keratinocytes with [3H]glycerol
in the presence and absence of 100 nM PMA elicited no
significant effect on glycerol uptake measured over a time
course of 10 min (Fig. 7, and slope values of PMA 0.998
F 0.009-fold over the control value of 1.00, determined as
described in Section 2 and in Ref. [21]; n = 3). However,
pretreatment of keratinocytes for 30 min with vehicle or
PMA prior to addition of radiolabeled glycerol for 5 min
resulted in a PMA-induced decrease in glycerol uptake (Fig.
8), suggesting an effect of phorbol ester on glycerol trans-
port that requires time (greater than 10 min) to develop.
Thus, a PMA-elicited decrease in glycerol uptake could
presumably account for, at least partially, the phorbol ester-
induced reduction in PG synthesis (measured over 30 min).
These results, together with the inability of 1,25-dihydrox-
yvitamin D3 to increase PG formation, suggests that theFig. 7. The phorbol ester, PMA does not induce PG formation despite
activating PLD. Near-confluent keratinocytes were incubated without
radiolabel (for PG production) or prelabeled with 2.5 ACi/ml [3H]oleate
(for phosphatidylethanol (PEt) formation) for 20–24 h. The cells were then
stimulated for 30 min with vehicle (0.05–0.1% DMSO; Con) or 100 nM
PMA in the presence of [3H]glycerol (for PG production), as described in
Section 2, or in the presence of 0.5% ethanol (for PEt formation). Reactions
were terminated by the addition of 0.2% SDS (F 5 mM EDTA) and
radiolabeled PG or PEt was extracted, separated by thin-layer chromatog-
raphy and quantified. Values are expressed as -fold over control and represent
the meansF S.E. of three separate experiments performed in duplicate or
triplicate; *P < 0.02 versus the appropriate control by an unpaired Student’s
t-test.
20 mM HEPES and 1 ACi/ml [3H]glycerol. For both sets of samples,
radiolabeled glycerol uptake was measured as described in Section 2.
Values represent the means of three (no pretreatment) or five (30-min
pretreatment) separate experiments performed in duplicate or triplicate;
*P< 0.001 versus the control value of 100% (dotted line).production of PG is not a universal corollary of PLD
activation.4. Discussion
An interesting and useful property of PLD has been its
ability to utilize primary alcohols for the production of
novel phosphatidylalcohols in a transphosphatidylation re-
action. This characteristic has been exploited by signal
transduction researchers to measure PLD activity specifical-
ly and to inhibit PLD-mediated signal generation. However,
the question remains: why should PLD retain this ability to
use unphysiological alcohols, such as ethanol and butanol,
in the absence of evolutionary pressure to do so? We
hypothesized that in fact, there is a physiological alcohol,
glycerol, for which PLD retains this enzymatic action.
Indeed, in in vitro experiments, PLD-2 was demonstrated
to possess the capacity to utilize glycerol as a substrate for
the transphosphatidylation reaction (Fig. 1). Furthermore,
we speculated that by utilizing glycerol for the transphos-
phatidylation reaction, PLD generates a potential lipid
signaling molecule, PG.
The question arises: which PLD isoform is likely to
account for the elevated extracellular calcium-induced PG
synthesis observed in keratinocytes? Based in part on our
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porin-3 in caveolin-rich membrane microdomains [21], we
hypothesize that PLD-2 is the isoform responsible for
using glycerol as a primary physiological alcohol to
synthesize PG in these cells. Aquaporin-3 is a member
of the aquaporin family of water channels; however, it
belongs to the subfamily of aquaglyceroporins that also
transport glycerol (reviewed in Refs. [30,31]). In fact,
aquaporin-3 efficiently transports glycerol but is quite
inefficient in water transport [32]. Aquaporin-3 protein
expression has been shown to localize to the basal layer
of the epidermis [33]. Consistent with this result, our study
demonstrated decreased aquaporin-3 mRNA and protein
expression [21] upon stimulation of primary keratinocytes
with the differentiating agents, elevated extracellular calci-
um concentration and 1,25-dihydroxyvitamin D3 (reviewed
in Refs. [34,35]). The reduced expression also resulted in
inhibited function, in that radiolabeled glycerol uptake was
decreased by both high (1 mM) extracellular calcium
concentration and 1,25-dihydroxyvitamin D3 [21]. On the
other hand, the ability of 125 AM calcium to trigger a
maximal increase in PG production is likely the result of
its stimulation of PLD activity as well as its enhancement
of glycerol uptake. This conclusion is based on the ability
of ethanol to inhibit elevated calcium concentration-in-
duced but not basal PG synthesis (Fig. 5), indicating
activation of PLD by this treatment, as well as on the
observed stimulation of radiolabeled phosphatidic acid
formation (Figs. 2 and 6), which suggests that enhanced
radioactive glycerol uptake contributes to increased incor-
poration of the radioactivity into the phospholipid back-
bone. Additional evidence that 125 AM calcium stimulates
PLD activity is provided by the experiments demonstrating
increased radiolabeled phosphatidylethanol production in
[3H]oleate-labeled cells exposed to ethanol. Inhibition of
glycerol uptake by higher calcium concentrations probably
explains the biphasic PG production observed in response
to various calcium concentrations (Fig. 3). Interestingly,
PMA also inhibited glycerol uptake (Fig. 8), consistent
with the idea that PKC modulates aquaporin-3 function, as
has been observed for aquaporin-4 [36–38]. High calcium
concentrations are also reported to stimulate PKC activity
([39] and reviewed in Ref. [34]), and this may represent
the mechanism by which high calcium levels inhibit
glycerol uptake [21].
The ability of elevated extracellular calcium concentra-
tions to stimulate PG production, whereas the additional
keratinocyte differentiating agents, 1,25-dihydroxyvitamin
D3 and PMA did not, suggests an important difference in the
mechanism by which these three agents trigger the differ-
entiative response. This lack of a completely common or
overlapping mechanism is also suggested by data in the
literature. Thus, maximal elevated extracellular calcium and
1,25-dihydroxyvitamin D3 concentrations act synergistically
to increase various markers of keratinocyte differentiation
([40] and reviewed in Ref. [35]), rather than less thanadditively as would be expected if the two agents utilized
a completely common pathway. In addition, PMA is known
to produce changes in keratinocytes consistent with induc-
tion of late (granular) differentiation and actually inhibits
markers of early differentiation [41], in contrast to the
effects of elevated extracellular calcium and 1,25-dihydrox-
yvitamin D3 levels (reviewed in Ref. [35]). PLD-1 has been
proposed to mediate, at least in part, 1,25-dihydroxyvitamin
D3-induced keratinocyte late differentiation [1], based on
the findings that exogenous (bacterial) PLD can induce
keratinocyte differentiation [4] and 1,25-dihydroxyvitamin
D3 increases PLD-1 expression and activity [6]. On the
other hand, 1,25-dihydroxyvitamin D3 does not enhance PG
formation (Figs. 2 and 4), nor does PMA (Fig. 7). Since
PMA is reported to activate PLD-1 to a greater extent than
PLD-2 [10], in keratinocytes 1,25-dihydroxyvitamin D3
does not increase PLD-2 expression [6] and PLD-2 is co-
localized with the glycerol channel aquaporin-3 [21], we
speculate that in keratinocytes radiolabeled PG production
upon exposure to glycerol may be a measure of PLD-2
activation. Thus, this assay may provide a means to monitor
the activity of a single PLD, PLD-2, in an intact cell system
expressing both PLD isoforms.
An interesting aspect of these studies was the observed
formation of phosphatidylcholine and phosphatidic acid
upon addition of radiolabeled glycerol. In PG the glycerol
is presumably incorporated, at least in part, as the headgroup
in a transphosphatidylation reaction, since the incorporation
can be inhibited by ethanol (Fig. 5). Indeed, in in vitro
experiments utilizing bacterial PLD to release phospholipid
headgroups, we found that elevated extracellular calcium
pretreatment enhanced the incorporation of glycerol into the
headgroup position (Fig. 6). In phosphatidylcholine and
phosphatidic acid, the glycerol is most likely incorporated
into the phospholipid as a glycerol backbone. Phosphatidic
acid is formed de novo by the addition of two fatty acids
(via fatty-acyl CoAs) to glycerol 3-phosphate, produced by
the action of glycerol kinase on glycerol; the subsequent
addition of choline (via CDP-choline) to dephosphorylated
phosphatidic acid (diacylglycerol) produces phosphatidyl-
choline. Since, radiolabeled glycerol was added for a total of
30 min only, our result would suggest rapid and active
phospholipid synthesis. This idea is consistent with the role
of keratinocytes in generating the lipids required to form the
water permeability barrier of skin (reviewed in Ref. [42]). It
was also shown that radiolabeled glycerol is incorporated
into the backbone of PG, as well, accounting partially for
the increase in radiolabeled PG formation. Thus, our results
confirm that PG synthesis can occur in at least two ways:
through a PLD-mediated transphosphatidylation reaction
and via the more traditional route of the addition of
glycerol-3-phosphate to CDP-diacylglycerol and subsequent
removal of the phosphate group, as has been reported on the
web site of the Lipid Analysis Group of the Scottish Crop
Research Unit (URL address: http://www.lipid.co.uk/
infores/Lipids/pg).
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that PG is a lipid second messenger in some cell systems.
For instance, in fibroblasts, Murray and Fields [43] have
identified PG as a PKC-hII activating factor required for
progression to mitosis. The Elias group [44–46] also
identified a protein kinase (PK-P, for PG-dependent protein
kinase) in human spleen that could be activated by PG and
phosphatidylinositol. This investigator also observed an
ability of PG to stimulate the activity of PKC-u and
provided evidence that this signaling pathway was respon-
sible for moesin phosphorylation in activated human leuko-
cytes [47]. These observations suggest a possible signaling
function for PG. In addition, in some systems PG may be
necessary for protein–protein interactions. Thus, in Syne-
chocystis sp., a type of cyanobacteria, and spinach, assem-
bly of photosystem II in the thylakoid membrane requires
PG [48,49]. Finally, two PG molecules can be condensed to
produce cardiolipin, a lipid essential for normal mitochon-
drial function. Indeed, recent evidence indicates a role for
cardiolipin in assembly and function of electron-transfer
chain proteins [50]. Furthermore, both cardiolipin and PG
can restore the high membrane potential of and prevent
cytochrome c release from mitochondria [51], suggesting a
possible role in modulating apoptosis.
What might be the role of PG in keratinocytes? Based on
the localization of glycerol-transporting aquaporin-3 to the
basal layer in skin, one might expect this signaling pathway
to function in a proliferative capacity or perhaps in early
differentiation events. This idea is consistent with the
observation that radiolabeled PG production is stimulated
maximally by an intermediate calcium concentration (125
AM; Fig. 3) known to induce near-maximal expression of
keratin-1 [41], a marker of early differentiation. Such an
interpretation would also be supported by the data indicating
a role for PG in PKC-hII-mediated mitotic progression [43].
While a previous study has reported no detectable expres-
sion of PKC-h by northern analysis of mouse keratinocytes
[52], other studies in both mouse and human have suggested
expression of this isoform in keratinocytes [53,54]. Obvi-
ously, additional studies are required to resolve this issue.
On the other hand, recent characterization of an aquaporin-3
null mouse mutant indicates the importance of this aqua-
glyceroporin to normal skin physiology. These null mice
display an epidermal phenotype characterized by dry skin
with altered water-holding capacity [55], as well as de-
creased elasticity and delayed wound repair [56] and a
reduction in the epidermal glycerol concentration [56,57].
A similar phenotype is seen in the asebia mouse model:
these mice, which lack sebaceous glands, also demonstrate
reduced epidermal glycerol content and alterations in epi-
dermal function [58]. In both the aquaporin-3 knockout and
asebia mouse model, the phenotype can be corrected by
topical glycerol application, but not application of another
humectant, [57,58], suggesting a role for glycerol beyond its
osmotic activity. Based on our results, we speculate that the
decreased formation of PG in aquaporin-3 null and asebiamice results in defects in keratinocyte growth and/or differ-
entiation that result in the abnormal skin physiology ob-
served in these mutants.
A final point remains to be addressed: the source of
glycerol in vivo. In amniotic fluid, glycerol concentrations
are in the micromolar range [29], suggesting a plausible role
for PLD, glycerol uptake mechanisms and PG in uterine
epidermal development. The glycerol concentration in the
serum is also in the micromolar range (f 50 AM) and
increases with exercise (tof 200 AM) as mono-, di- and
triglycerides are metabolized to their constituent fatty acids
and glycerol [59]. Lipid metabolism is known to occur in the
epidermis as well (reviewed in Ref. [42]); thus, the possibil-
ity exists that glycerol levels are significant within the skin
itself as a result of this degradation of neutral lipids. Indeed,
in normal mice, glycerol concentrations in the stratum
corneum, the upper layer of the epidermis, are on the order
of 0.6–0.8 nmol/Ag of protein [56,58]. Finally, many skin
cosmetics and wound salves have glycerol (also called
glycerine) as a primary ingredient. It is, of course, tempting
to speculate an involvement of PLD, aquaporin-3 and PG in
the beneficial effect of glycerol on skin health. Regardless, in
view of the potential importance of this phospholipid in skin
biology, additional research is necessary.Acknowledgements
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